Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Gliptins

Gliptins

  • Diabetes (430)
    • Blood Glucose Meters (4)
    • Complications (101)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (61)
    • Drug-Induced Hypo/Hyperglycemia (96)
    • Monitoring (79)
    • Natural Medicines/Supplements (8)
    • Prevention (26)
    • Treatment (193)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (16)
      • Gliptins (60)
      • Glitazones (69)
      • GLP-1 (28)
      • Incretin Enhancers/Mimetics (44)
      • Insulin (114)
      • Meglitinides (30)
      • Metformin (86)
      • SGLT2 Inhibitors (48)
      • Sulfonylureas (76)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (9)
  • Hyperglycemia (24)
  • Hypoglycemia (22)
  • Other (15)
  • Prediabetes (2)
  • Resources (128)
  • Thyroid Disorders (41)
31 - 45 of 60 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Listen for Gliptin Patients Complaining of Severe Joint Pain October 2015
Other: Canada Vigilance October 2015
Commentary: DPP-4 Inhibitors (Gliptins) and Severe Joint Pain October 2015
Article: Stay Alert for Patients With Diabetes Being Switched to "2-In-1" Products June 2015
Article: Stay Alert for Insulin Dosing Changes During Pregnancy April 2015
Commentary: Treatment of Gestational Diabetes April 2015
Article: Think of Nesina as a "Me Too" Similar to Januvia, Onglyza, and Trajenta January 2015
Article: questions about when and how patients with type 2 diabetes should use insulin June 2014
Article: emphasis on improving care in diabetes patients April 2014
Article: help improve medication adherence December 2013
Patient Education: Tips for Sticking With Your Meds November 2013
Article: more emphasis on preventing and treating dangerously LOW blood sugar in patients with diabetes August 2013
Patient Education: How to Handle Low Blood Sugar August 2013
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) August 2013
Article: more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis April 2013
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved